(Q40801133)

English

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

scientific article

Statements

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial (English)
Karp JE
Merz WG
Hendricksen C
Laughon B
Redden T
Bamberger BJ
Bartlett JG
Saral R
Burke PJ
1 January 1987
106

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit